Here are the 10-K annual reports from Tradewinds Unvl (TRWD) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow TRWD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TRWD filings page.
Tradewinds Universal, Inc. reports a larger 2025 loss and files an amended annual report to add auditor consent without changing prior disclosures. Revenue fell to about $133,222, mainly from licensing and distribution rights, down from $171,596 in 2024 as it exited physical product sales.
Operating expenses jumped to roughly $1,026,099, driven by about $886,105 in consulting and professional costs, leading to a net loss of approximately $892,877 and an accumulated deficit near $1,183,067. Cash stood at $16,638 within total assets of about $307,333, and auditors highlighted substantial doubt about the company’s ability to continue as a going concern. The company shifted toward licensing, acquired additional intangible assets, and secured a $10.0 million common stock purchase agreement to access future equity financing.
Tradewinds Universal reported 2025 revenue of $133,222, down from $171,596 in 2024, as it shifted away from physical protein bar sales toward licensing and distribution rights. With no cost of goods sold, gross margin reached 100%, but operating expenses surged to $1,026,099, driven mainly by consulting and stock-based compensation.
The company recorded a 2025 net loss of $892,877 and ended the year with total assets of $307,333, including $216,500 in intangible assets, and cash of $16,638. Accumulated deficit rose to $1,183,067, and auditors highlighted substantial doubt about its ability to continue as a going concern.
Strategically, Tradewinds is focusing on licensing its canine pain relief formula, selling distribution and licensing rights, and pursuing new verticals. In August 2025 it signed a Letter of Intent with Peppermint Hippo™ to enter the nightlife and hospitality sector. Subsequent to year-end, it entered a $10.0 million common stock purchase agreement with RH2 Equity Partners to provide potential future equity funding.